Related Experiment Video
Updated: May 16, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development
Fenja Knoepp1, Shariq Abid2,3, Amal Houssaini2,4
1Excellence Cluster Cardio-Pulmonary Institute, Universities of Giessen and Marburg Lung Center, Member of the German Center for Lung Research, Justus Liebig University (F.K., M.Y.G., A.G., S.K., I.B.-M., K.Q., D.F.-N., N.W.).
The mechanosensitive ion channel Piezo1 in pulmonary arterial smooth muscle cells drives pulmonary hypertension by increasing cell proliferation and vasoconstriction. Blocking Piezo1 protects against PH development and preserves lung vasculature.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Cellular Mechanobiology
Background:
- Pulmonary hypertension (PH) is a progressive, incurable disease characterized by pulmonary arterial smooth muscle cell (PASMC) contraction and proliferation.
- Altered mechanical stress in pulmonary arteries is a key stimulus for PASMC dysfunction during PH.
- Mechanosensitive ion channels, like Piezo1, translate mechanical stimuli into cellular responses relevant to PH pathogenesis.
Purpose of the Study:
- To investigate the specific role of Piezo1 in PASMCs in the development and progression of PH.
- To determine if targeting Piezo1 in PASMCs can ameliorate PH-related pathology.
Main Methods:
- Assessed Piezo1 expression in PASMCs and lung tissues from PH patients.
- Utilized smooth muscle cell-specific, conditional Piezo1 knockout mouse models.
- Evaluated Piezo1 function in isolated mouse lungs, pulmonary arteries, and in vivo after chronic hypoxia-induced PH.
Main Results:
- PASMCs from PH patients showed elevated Piezo1 expression and proliferation.
- Piezo1 knockout in PASMCs prevented hypoxia-induced proliferation and reduced vasoconstriction.
- Piezo1-deficient mice were protected against PH, exhibiting improved hemodynamics and preserved lung capillaries.
Conclusions:
- Piezo1 in PASMCs is a critical mediator in PH pathogenesis.
- Targeting Piezo1 influences pulmonary vascular tone, arterial remodeling, and endothelial cell senescence.
- Piezo1 represents a potential therapeutic target for treating pulmonary hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Regulation of Angiogenesis and Blood Supply
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

